Life Sciences

IAM Patent 1000 rankings 2023
Carpmaels & Ransford is top ranked again for patent prosecution
Read More
27
Jun
2023
Managing IP EMEA Awards 2023
Carpmaels & Ransford awarded UK Patent Prosecution Firm of the Year at the Managing IP EMEA Awards 2023
Read More
22
Jun
2023
Financial Times: Europe’s Leading Patent Law Firms 2023
Carpmaels & Ransford listed again as one of Europe’s leading patent firms
Read More
14
Jun
2023
The UPC has now opened
A new era for European patent law – the biggest change in five decades
Read More
01
Jun
2023
Carpmaels attends Enlarged Board of Appeal hearing on priority entitlement
The EPO Enlarged Board of Appeal held its oral proceedings on Friday 26th May 2023, to consider the law on formal priority entitlement. Carpmaels & Ransford attended the hearing on behalf of Novartis
Read More
30
May
2023
Carpmaels in Conversation: Ep. 25 – Can an undisclosed disclaimer be used to restore a loss of partial priority?
Episode overview
Read More
23
May
2023
New certainty for handling of cases by the central division of the UPC
For the time being, UPC actions on many life science, pharmaceutical and medtech patents will be heard in Paris, with some cases to be heard in Munich
Read More
16
May
2023
The Doctrine of Equivalents – where are we now?
2023 update
Read More
10
May
2023
Carpmaels in Conversation: Ep. 23 – Recent changes to the EPO’s Guidelines for Examination
Episode overview
Read More
05
May
2023
Who’s Who Legal 2023: Life Sciences 2023
Carpmaels & Ransford partners recognised as leading patent litigation lawyers in life sciences
Read More
04
May
2023

Type

Service

Sector

Archive